Xoten 10mg Tablet contains Rosuvastatin, a potent HMG-CoA reductase inhibitor used primarily to lower elevated levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol in patients with hypercholesterolemia and mixed dyslipidemia. By competitively inhibiting the enzyme HMG-CoA reductase, Rosuvastatin effectively reduces cholesterol biosynthesis in the liver, leading to increased clearance of LDL particles from the bloodstream. Xoten is indicated for the management of primary hyperlipidemia, including heterozygous familial hypercholesterolemia, and for the prevention of cardiovascular disease in patients at high risk. The 10mg dosage is typically initiated to achieve lipid-lowering goals, with adjustments made based on patient response and tolerability. Clinical studies have demonstrated that Rosuvastatin not only lowers LDL-C but also modestly increases high-density lipoprotein cholesterol (HDL-C) and reduces triglycerides. Xoten should be used as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances; rare but serious risks include myopathy and hepatotoxicity. Liver function tests and creatine kinase levels should be monitored periodically during therapy. Xoten is contraindicated in patients with active liver disease or pregnancy.